• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性非息肉病性结直肠癌(林奇综合征I型和II型)患者的识别与治疗。

Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II).

作者信息

Fitzgibbons R J, Lynch H T, Stanislav G V, Watson P A, Lanspa S J, Marcus J N, Smyrk T, Kriegler M D, Lynch J F

出版信息

Ann Surg. 1987 Sep;206(3):289-95. doi: 10.1097/00000658-198709000-00007.

DOI:10.1097/00000658-198709000-00007
PMID:3632093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1493182/
Abstract

Primary genetic factors are etiologic in at least 5-10% of patients with colon cancer. The polyposis syndromes (FPC) are easily identified examples because of the spectacular number of polyps. The hereditary nonpolyposis syndromes (HNPCC), although five times more common than FPC, are usually not recognized because they do not have such a distinctive clinical, premonitory genetic marker. Colorectal cancer expression was surveyed in 10 extended, thoroughly documented HNPCC kindreds. One hundred sixteen patients were found to have 183 colorectal cancers. Despite the striking family history, less than 5% were correctly treated by subtotal colectomy. This provided a unique opportunity to study the natural history. Five findings differed significantly (p less than 0.05) from patients with sporadic colon cancer: (1) mean age of initial colon cancer diagnosed was 45.6 years; (2) 69.1% of first colon cancers were located proximal to the splenic flexure of the colon; (3) 18.1% had synchronous colon cancer; (4) 24.2% had metachronous colon cancer develop with life table analysis showing the risk for a metachronous lesion at 10 years to be 40%; and (5) only 23.3% of cancers were located in the sigmoid colon or rectum. Based on this data, it is recommended that the family history of all patients with a newly diagnosed colon cancer be evaluated for evidence of this syndrome. If an autosomal dominant inheritance pattern emerges, an in-depth genetic investigation is indicated. When HNPCC is confirmed, the following recommendations apply: a subtotal abdominal colectomy is indicated at the time of the initial colon cancer because of the risk of synchronous and metachronous lesions. The rectum should be spared in favor of careful lifetime surveillance because of the proclivity for proximal colon cancer involvement. As yet unaffected members of a newly diagnosed HNPCC kindred who are in the "direct genetic line" should be cautioned that they are at 50% risk and must begin an intensive surveillance program beginning in the third decade with careful attention to the right colon. Patients from newly diagnosed HNPCC families who have had a previous conventional colectomy for colon cancer should, at the very least, enter an intensive surveillance program; a prophylactic completion subtotal colectomy should be considered for patients who are less than totally compliant.

摘要

原发性遗传因素在至少5%-10%的结肠癌患者中是病因性的。息肉病综合征(FPC)是容易识别的例子,因为息肉数量惊人。遗传性非息肉病综合征(HNPCC)虽然比FPC常见五倍,但通常未被识别,因为它们没有如此独特的临床、先兆性遗传标记。对10个经过充分记录的HNPCC大家族进行了结直肠癌表达情况的调查。发现116名患者患有183例结直肠癌。尽管有明显的家族病史,但不到5%的患者通过结肠次全切除术得到了正确治疗。这提供了一个研究自然病史的独特机会。与散发性结肠癌患者相比,有五项发现有显著差异(p<0.05):(1)首次诊断出结肠癌的平均年龄为45.6岁;(2)69.1%的首例结肠癌位于结肠脾曲近端;(3)18.1%有同时性结肠癌;(4)24.2%有异时性结肠癌发生,生命表分析显示10年时异时性病变的风险为40%;(5)只有23.3%的癌症位于乙状结肠或直肠。基于这些数据,建议对所有新诊断为结肠癌的患者的家族病史进行评估,以寻找该综合征的证据。如果出现常染色体显性遗传模式,则需进行深入的基因调查。当HNPCC得到证实时,适用以下建议:由于存在同时性和异时性病变的风险,在首次诊断出结肠癌时应进行腹部结肠次全切除术。应保留直肠,以便进行仔细的终身监测,因为近端结肠癌受累的倾向较大。新诊断的HNPCC大家族中尚未受影响的处于“直系基因系”的成员应被告知,他们有50%的风险,必须从三十岁开始启动强化监测计划,并密切关注右半结肠。新诊断的HNPCC家族中曾因结肠癌接受过传统结肠切除术的患者,至少应进入强化监测计划;对于不完全依从的患者,应考虑进行预防性结肠次全切除术。

相似文献

1
Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II).遗传性非息肉病性结直肠癌(林奇综合征I型和II型)患者的识别与治疗。
Ann Surg. 1987 Sep;206(3):289-95. doi: 10.1097/00000658-198709000-00007.
2
Hereditary nonpolyposis colorectal cancer--Lynch syndromes I and II.遗传性非息肉病性结直肠癌——林奇综合征I型和II型。
Gastroenterol Clin North Am. 1988 Dec;17(4):679-712.
3
Natural history of colorectal cancer in hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II).
Dis Colon Rectum. 1988 Jun;31(6):439-44. doi: 10.1007/BF02552613.
4
Combined molecular and clinical approach for decision making for surgery in HNPCC patients: a report on three cases in two families.用于指导遗传性非息肉病性结直肠癌(HNPCC)患者手术决策的分子与临床联合方法:两个家族中三例病例报告
Int J Colorectal Dis. 2001 Nov;16(6):402-7. doi: 10.1007/s003840100349.
5
Patterns of surgery in patients belonging to amsterdam-positive families.阿姆斯特丹阳性家族患者的手术模式。
Dis Colon Rectum. 2003 May;46(5):617-20. doi: 10.1007/s10350-004-6619-9.
6
[Hereditary non polyposis colorectal cancer (HNPCC). A clinical and genetic entity].[遗传性非息肉病性结直肠癌(HNPCC)。一种临床和遗传实体]
Minerva Chir. 2002 Feb;57(1):63-72.
7
Metachronous serrated neoplasia is uncommon after right colectomy in patients with methylator colon cancers with a high degree of microsatellite instability.右半结肠切除术后,伴有高度微卫星不稳定的甲基化结肠癌患者发生异时性锯齿状肿瘤较为少见。
Dis Colon Rectum. 2014 Jan;57(1):39-46. doi: 10.1097/01.dcr.0000437690.18709.76.
8
[Identification of 2 families with hereditary nonpolyposis colonic cancer (HNPCC) and the Amsterdam criteria. Relevance of the genealogic tree and follow-up].[两例遗传性非息肉病性结肠癌(HNPCC)家族的鉴定及阿姆斯特丹标准。系谱树和随访的相关性]
Med Clin (Barc). 2000 Jan 22;114(2):56-9. doi: 10.1016/s0025-7753(00)71189-4.
9
[Hereditary nonpolyposis colorectal carcinoma (HNPCC): surgical aspects].[遗传性非息肉病性结直肠癌(HNPCC):手术方面]
Praxis (Bern 1994). 2001 Mar 22;90(12):483-9.
10
Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. International Collaborative Group on HNPCC.腹部结肠切除术后遗传性非息肉病性结直肠癌患者的直肠癌风险。遗传性非息肉病性结直肠癌国际协作组
Ann Surg. 1997 Feb;225(2):202-7. doi: 10.1097/00000658-199702000-00008.

引用本文的文献

1
Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines.小核酸疗法全景:作为下一代药物从实验室走向临床
Signal Transduct Target Ther. 2025 Mar 10;10(1):73. doi: 10.1038/s41392-024-02112-8.
2
Surgical outcomes of left hemicolon sparing resection versus extensive resection in treating synchronous colorectal cancer involving the right-sided colon and sigmoid colon or rectum.左半结肠切除术与广泛切除术治疗累及右半结肠、乙状结肠或直肠的同时性结直肠癌的手术效果比较。
World J Surg Oncol. 2023 Apr 13;21(1):131. doi: 10.1186/s12957-023-03012-x.
3
Exome and immune cell score analyses reveal great variation within synchronous primary colorectal cancers.外显子组和免疫细胞评分分析揭示了同步原发性结直肠癌中的巨大变异性。
Br J Cancer. 2019 Apr;120(9):922-930. doi: 10.1038/s41416-019-0427-4. Epub 2019 Mar 21.
4
Familial Colorectal Cancer: Understanding the Alphabet Soup.家族性结直肠癌:解读复杂因素
Clin Colon Rectal Surg. 2016 Sep;29(3):185-95. doi: 10.1055/s-0036-1584290.
5
Mutation profiles of synchronous colorectal cancers from a patient with Lynch syndrome suggest distinct oncogenic pathways.一名林奇综合征患者的同步性结直肠癌的突变谱提示不同的致癌途径。
J Gastrointest Oncol. 2016 Jun;7(3):E64-71. doi: 10.21037/jgo.2016.01.07.
6
Colorectal carcinoma in the first decade of life: a systematic review.10岁前儿童的结直肠癌:一项系统综述
Int J Colorectal Dis. 2015 Aug;30(8):1001-6. doi: 10.1007/s00384-015-2202-1. Epub 2015 Apr 28.
7
Hereditary colorectal cancer and Lynch syndrome.遗传性结直肠癌与林奇综合征。
BMC Proc. 2013 Apr 4;7 Suppl 2(Suppl 2):K2. doi: 10.1186/1753-6561-7-S2-K2. eCollection 2013.
8
Quality colonoscopy and risk of interval cancer in Lynch syndrome.林奇综合征中高质量结肠镜检查与间期癌风险
Int J Colorectal Dis. 2013 Dec;28(12):1643-9. doi: 10.1007/s00384-013-1745-2. Epub 2013 Jul 16.
9
Current Lynch syndrome tumor screening practices: a survey of genetic counselors.当前林奇综合征肿瘤筛查实践:遗传咨询师调查
J Genet Couns. 2014 Feb;23(1):38-47. doi: 10.1007/s10897-013-9603-5. Epub 2013 May 15.
10
Surgical treatment of hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome).遗传性非息肉病性结直肠癌(HNPCC,林奇综合征)的外科治疗。
Fam Cancer. 2013 Jun;12(2):295-300. doi: 10.1007/s10689-013-9626-y.

本文引用的文献

1
Colonoscopy: its role in cancer of the colon and rectum.结肠镜检查:其在结肠癌和直肠癌中的作用。
Dis Colon Rectum. 1982 Sep;25(6):532-8. doi: 10.1007/BF02564161.
2
Surveillance and management of patients at high genetic risk for ovarian carcinoma.
Obstet Gynecol. 1982 May;59(5):589-96.
3
Surveillance/management of an obligate gene carrier: the cancer family syndrome.
Gastroenterology. 1983 Feb;84(2):404-8.
4
The true incidence of synchronous cancer of the large bowel. A prospective study.大肠同时性癌的真实发病率。一项前瞻性研究。
Am J Surg. 1984 Mar;147(3):330-3. doi: 10.1016/0002-9610(84)90161-2.
5
Cancer of the colon, rectum, and anus: a review of 2313 cases.
Cancer. 1974 Sep;34(3):suppl:951-9. doi: 10.1002/1097-0142(197409)34:3+<951::aid-cncr2820340725>3.0.co;2-9.
6
Colorectal cancer in a nuclear family. Familial or hereditary?
Dis Colon Rectum. 1985 May;28(5):310-6. doi: 10.1007/BF02560430.
7
Restorative proctocolectomy and ileal reservoir.修复性直肠结肠切除术和回肠贮袋术
Mayo Clin Proc. 1986 Apr;61(4):283-6. doi: 10.1016/s0025-6196(12)61931-4.
8
Cancer statistics, 1987.1987年癌症统计数据。
CA Cancer J Clin. 1987 Jan-Feb;37(1):2-19. doi: 10.3322/canjclin.37.1.2.